CVS Health Co. (NYSE:CVS) Shares Purchased by Cetera Investment Advisers

Cetera Investment Advisers raised its position in CVS Health Co. (NYSE:CVS - Free Report) by 2.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 318,779 shares of the pharmacy operator's stock after acquiring an additional 6,524 shares during the quarter. Cetera Investment Advisers' holdings in CVS Health were worth $14,310,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in CVS. Principal Financial Group Inc. increased its position in shares of CVS Health by 4.8% during the third quarter. Principal Financial Group Inc. now owns 1,434,476 shares of the pharmacy operator's stock worth $90,200,000 after acquiring an additional 66,244 shares during the period. Watts Gwilliam & Co. LLC raised its position in CVS Health by 9.8% in the 4th quarter. Watts Gwilliam & Co. LLC now owns 7,302 shares of the pharmacy operator's stock valued at $334,000 after purchasing an additional 650 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in shares of CVS Health by 1.3% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 173,643 shares of the pharmacy operator's stock valued at $7,795,000 after buying an additional 2,256 shares during the period. Ridgewood Investments LLC grew its position in shares of CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock worth $28,000 after buying an additional 450 shares in the last quarter. Finally, Graypoint LLC raised its holdings in CVS Health by 15.2% in the fourth quarter. Graypoint LLC now owns 5,187 shares of the pharmacy operator's stock valued at $233,000 after acquiring an additional 683 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on CVS shares. Cantor Fitzgerald raised shares of CVS Health from a "neutral" rating to an "overweight" rating in a research report on Wednesday, February 12th. Piper Sandler raised their price target on CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a research note on Friday, March 21st. Mizuho upped their price objective on CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Barclays raised their target price on CVS Health from $73.00 to $82.00 and gave the stock an "overweight" rating in a research report on Friday, May 2nd. Finally, Edward Jones upgraded shares of CVS Health from a "hold" rating to a "buy" rating in a research note on Thursday, January 30th. Three investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $74.81.

CVS Health Stock Performance

Shares of CVS opened at $66.98 on Friday. The stock has a market capitalization of $84.45 billion, a P/E ratio of 18.30, a P/E/G ratio of 0.98 and a beta of 0.60. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $72.51. The company's fifty day moving average is $66.96 and its two-hundred day moving average is $59.03.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.63. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The firm had revenue of $94.59 billion during the quarter, compared to analysts' expectations of $93.07 billion. During the same period in the prior year, the company posted $1.31 earnings per share. The firm's revenue for the quarter was up 7.0% on a year-over-year basis. On average, sell-side analysts predict that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.97%. The ex-dividend date of this dividend was Tuesday, April 22nd. CVS Health's payout ratio is 63.48%.

Insider Buying and Selling at CVS Health

In other CVS Health news, SVP James David Clark sold 7,513 shares of the stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total value of $498,487.55. Following the completion of the transaction, the senior vice president now directly owns 8,394 shares of the company's stock, valued at approximately $556,941.90. This trade represents a 47.23 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Michael F. Mahoney bought 30,000 shares of the firm's stock in a transaction on Tuesday, February 18th. The shares were purchased at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the transaction, the director now owns 39,356 shares of the company's stock, valued at $2,625,045.20. This represents a 320.65 % increase in their position. The disclosure for this purchase can be found here. 1.22% of the stock is owned by corporate insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.